Luliconazole (Lulise 1% Cream) is used to treat the fungal infections of the skin caused by the organisms such as Trichophyton rubrum and Epidermophyton floccosum. Luliconazole (Lulise 1% Cream) works ...
Review the side-effects of Luliconazole as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it’s ready to advance its 10% solution of luliconazole into Phase 3 ...
Cutaneous fungal infections remain a global health concern, with dermatophytic infections such as athlete’s foot, jock itch, and ringworm affecting millions of individuals. While luliconazole, an ...
The US Food and Drug Administration (FDA) has approved the azole antifungal luliconazole 1% cream (Luzu, Valeant Pharmaceuticals) to treat fungal infections, the company announced today. Luliconazole ...
TOPICA Pharmaceuticals, Inc., has announced positive results from its Phase 1/2a trial evaluating the safety, tolerability and pharmacokinetics of a 10% solution of luliconazole after maximal use ...
Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has launched a New Chemical Entity (NCE), Lulifin (Luliconazole), in the Indian Dermatology market. This follows a strategic ...
Topica Pharmaceuticals announced the enrollment of patients in a Phase 2 clinical trial evaluating luliconazole for the treatment of tinea pedis (athlete’s foot). This multi-center, randomized, double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results